Balsamic liniment (by vishnevsky)

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT BALMY LINIMENT (by Vishnevsky) (BALMYLINIMENT (byVishnevsky)

Composition:

Active substances: 1 g of the preparation contains bismuth tribromophenate (Xeroform) (calculated as 50% bismuth oxide and dry substance) 30 mg, birch tar 30 mg;

Excipients: colloidal anhydrous silicon dioxide, ricinus oil.

Pharmaceutical form. Liniment.

Main physico-chemical properties: liniment ranges from slightly yellowish to brown or brown with greenish or bluish tint, with a specific odor.

Pharmacotherapeutic group. Antiseptics and disinfectants. ATC code D08A X.

Pharmacological properties.

Pharmacodynamics.

Vishnevsky's balm liniment exerts a disinfecting, anti-inflammatory, and mild irritant effect on tissue receptors due to the components contained in its formulation. The drug promotes accelerated wound healing by normalizing tissue blood supply.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications.

• Abscesses;
• furuncles;
• pressure ulcers;
• lymphadenitis;
• lymphangitis;
• burns;
• frostbite;
• trophic ulcers.

Contraindications.

• Hypersensitivity to phenol and its derivatives;
• hypersensitivity to any component of the drug.

Interaction with other medicinal products and other forms of interaction.

When used simultaneously with other topical medicinal products on the same skin areas, new compounds with unpredictable effects may be formed.

Special precautions for use.

Consult a doctor before starting treatment!

The liniment is intended for external use only. Before applying a dressing, the wound should be cleaned from necrotic tissues, blisters should be opened, and the wound should be rinsed with an antiseptic solution.

Avoid contact of the liniment with mucous membranes. Hands should be thoroughly washed after application to prevent accidental contact of residual ointment with eyes, nose, or mouth. In case of contact, rinse thoroughly with large amounts of water.

Birch tar, an ingredient of the balsamic liniment, may increase sensitivity to sunlight; therefore, during summer, exposure to direct sunlight should be avoided while using this product.

If symptoms do not begin to improve, or if the condition worsens, or if any adverse reactions occur, discontinue use of the product and consult a doctor for further management.

Use during pregnancy or breastfeeding.

As the safety of using this product during pregnancy or breastfeeding has not been studied, it should only be used if the potential benefit justifies the potential risk to the fetus or infant.

Ability to affect reaction speed when driving or operating machinery.

There is no information available regarding the effect of the product on reaction speed when driving or operating machinery.

Method of Administration and Dosage.

For adults, apply the liniment externally as directed by a physician. Apply 2–3 times daily as a thin layer to affected skin areas or apply a dressing consisting of 5–6 layers of gauze soaked with the preparation. Fix the dressing in place and change it once every 2–3 days.

Dressings should be continued until complete clearance of the infected skin area.

Duration of treatment: from 6 to 20 days.

Children.

Safety and clinical efficacy of the drug in this age group have not been studied.

Overdose.

Possible manifestations of local allergic reactions (including rash, itching), which require antiallergic therapy.

Treatment: in case of accidental ingestion of a large amount of the gel, induce vomiting and seek medical advice immediately. Symptomatic therapy.

Side effects.

With prolonged use, local allergic reactions may occur (including hyperemia, itching, skin rashes such as urticaria, swelling), which require anti-allergic therapy. Photosensitization reactions are possible.

If any adverse reactions occur, discontinue use of the drug and consult a physician immediately for further management!

Shelf life. 5 years.

Do not use the drug after the expiry date stated on the packaging.

Storage conditions.

In the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging. 40 g in a tube and carton.

Supply category. Over-the-counter.

Manufacturer.

Public Joint-Stock Company "Scientific-Production Center "Borshchagivskiy Chemical and Pharmaceutical Plant".

Manufacturer's address and location of business activity.

17 Miru Street, Kyiv, 03134, Ukraine.